2020 International Symposium on The Latest Technology of Chronic Wound Treatment and Dermatology Was Successfully Held


On July 30, 2020, at 3:00 PM, the 2020 International Symposium on The Latest Technology of Chronic Wound Treatment and Dermatology was held in Guangzhou, China in the form of live. Hosted by professor Liu Xusheng, a leading figure in the department of burns, the conference announced for the first time the latest technology of disruptive regenerative medicine for the repair of damaged mitochondria. The technology was developed by KLOX and settled in Nansha, Guangzhou.


Professor Marco Romanelli, Chairman of the World Association for Wound Healing, Dr. Michael Nielsen, professor of The Technical University of Denmark and Chief Technology Officer of Klock Biomedical Group, and Dr. Ritu Gupta, an internationally renowned dermatologist, joined the conference online, Professor Huang Wenhua, dean of The School of Basic Medicine of Southern Medical University, Dr. Tang Xuhua from the First Affiliated Hospital of Sun Yat-sen University and others attended the conference in person. Relevant leaders of Nansha District, Guangzhou solemnly attended the meeting.


1614047787207138.jpg

Professor Liu, Xusheng chaired the meeting


Professor Michael Nielsen gave a keynote speech entitled "The effect of fluorescently targeted light energy on mitochondrial dynamics", focusing on the principle of action. Its theory is derived from the Nobel Prize in chemistry for paper "diagnosis using fluorescence microscopy techniques", mainly using photon converter, reduces the total cell number of mitochondria, increase a single volume, mitochondria and mitochondrial network (form) for complex branch network, which is a targeted treatment for diabetic complications of diabetic foot. According to authoritative data, every 30 seconds, a diabetic foot patient needs an amputation. According to a paper published in the British Medical Journal by the Chinese Medical Association on April 28, 2020, the total number of diabetes patients in China is estimated at 129.8 million, ranking first in the world. This technique has been clinically applied in the European Union, Canada, Australia and other countries and regions, and the rate of diabetic foot wound area regression reached 83.8% in the tenth week, showing remarkable curative effect.


23 academic papers on this subversive technology were published in SPIE (International Society of optical engineering, the international top society in the field of optics founded in 1955), Science Direct (the world's largest professional journal founded in 1880) and other international famous academic journals, and won the innovation award of the 2019 world mitochondrial conference.


Marco Romanelli, President of the World Federation of wound healing, Dr. Ritu Gupta of Australia, Professor Liu Xusheng of Sun Yat-sen University and Professor Huang Wenhua of Southern Medical University highly affirmed the clinical application prospect of this technology in China and Asia.


The settlement of the project has made important contributions to further establishing the leading position of medical technology in Guangdong, Hong Kong and Macao Greater Bay Area, introducing global high-end biotechnology talents and building a global biotechnology innovation and technology exchange platform.